HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bausch + Lomb Turns To Familiar Face As CEO, Brent Saunders

Executive Summary

Saunders will oversee the consumer health, pharma and medtech eye health and vision care specialist, returning to where he got his start as a chief executive before earning a reputation as one of industry’s biggest dealmakers.

You may also be interested in...

With ‘Roadmap To Accelerate Growth,’ Saunders Quick Out Of Gate In Return To Bausch + Lomb

“Multi-year plan with three phases, all with measurable, clear objectives” starts with “rewire company for optimal performance” before moving to “innovate and execute” and then to “accelerate growth,” CEO says.

HBW Executive Decisions: B+L Leadership Changes; CHPA Promotions; ANH Founder’s Larger Role

Bausch + Lomb CEO brings on colleagues from Allergan; American Herbalists Guild executive director receives ABC award; Joseph Betz joins ABC board of trustees; senior management changes in CHPA communications, foundation; ANH founder Ververk takes US helm, too.

HBW Executive Decisions: CDER Compliance Director, CRN Communications VP, Bayer, B+L CEOs

CDER Compliance director Furman no longer acting; former FDA communications director joins CRN; USANA marketing chief On Utah Business’s List; FTC launches Technology Office; and Bayer and Bausch + Lomb appoint CEOs.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts